Problems of vaccine prophylaxis of influenza in pregnant women


Cite item

Full Text

Abstract

Pregnant women are at high risk for the adverse course of respiratory diseases, among which the influenza is the one of the leading infections, of ten finishing tragically for most pregnant and her offspring. Due to the disproportionately high morbidity, mortality and adverse outcomes of pregnancy after influenza virus infection, pregnant females are classified as a priority group for vaccination. Immunization with inactivated influenza vaccine is one of the most important strategy to prevent both of influenza infection, its severe complications, and mitigating of the effects of the epidemic of influenza. There was accumulated sufficient evidence demonstrating that the vaccine promotes the diminution of clinical manifestations of influenza infection in pregnant women, as well, has a positive effect on the health of the newborns due to the active transport of maternal antibodies. In the review there are presented data on the safety, high immunogenicity and clinical efficacy of vaccination against influenza as for pregnant women as well for infants.

About the authors

V. L Maksakova

Research Institute of Influenza

Email: maksakova_v@mail.ru
канд. мед. наук, вед. науч. сотр. лаб. испытаний новых средств защиты от вирусных инфекций ФГБУ «НИИ гриппа» Минздрава России 15/17, Prof. Popov str., Saint-Petersburg, Russian Federation, 197376

O. S Konshina

Research Institute of Influenza

Email: olga.konshina@influenza.spb.ru
науч. сотр. лаб. испытаний новых средств защиты от вирусных инфекций ФГБУ «НИИ гриппа» Минздрава России 15/17, Prof. Popov str., Saint-Petersburg, Russian Federation, 197376

M. K Erofeeva

Research Institute of Influenza

Email: mariana.erofeeva@influenza.spb.ru
доктор мед. наук, руководитель лаб. испытаний новых средств защиты от вирусных инфекций ФГБУ «НИИ гриппа» Минздрава России 15/17, Prof. Popov str., Saint-Petersburg, Russian Federation, 197376

I. I Tokin

Research Institute of Influenza; North-Western State Medical University named after I.I. Mechnikov

Email: ivan.tokin@influenza.spb.ru
канд. мед. наук, зав. отд-нием экспериментальной терапии хронических вирусных гепатитов ФГБУ «НИИ гриппа» Минздрава России, доцент каф. инфекционных болезней Северо-Западного государственного медицинского университета им. И.И. Мечникова 15/17, Prof. Popov str., Saint-Petersburg, Russian Federation, 197376

References

  1. Афиногенова В.П., Кытько О. В. Грипп и беременность. Лечащий врач. 2010; (11): 9-11.
  2. Neuzil K.M., Reed G.W., Mitchel E.F., Simonsen L., Griffin M.R. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am. J. Epidemiol. 1998; 148 (11): 1094-102.
  3. Schanzer D.L., Langley J.M., Tam T.W.S. Influenza-attributed hospitalisation rates among pregnant women in Canada 1994-2000. J. Obstet. Gynaecol. Can. 2007; 29 (8): 622-9.
  4. ECDC Scientific Advice on Seasonal Influenza Vaccination of Children and Pregnant Women: ECDC Technical Report / European Centre for Disease Prevention and Control. Stockholm: ECDC; 2012: 68.
  5. Centers for Disease Control and Prevention (CDC). Deaths and hospitalisations related to 2009 pandemic influenza A (H1N1) - Greece, May 2009-February 2010. Morbid. Mortal. Wkly Rep. 2010; 59 (22): 682-6.
  6. CDC. Guidelines for Vaccinating Pregnant Women: from Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention; 2007. [cited 2011 May 9]. - Available from: http://www.cdc.gOv/vaccines/pubs/preg-guide.htm#5
  7. Fuhrman C., Bonmarin I., Paty A.C. et al. Severe hospitalised 2009 pandemic influenza A (H1N1) cases in France, July - 15 November 2009. Surveillance and outbreak reports. Euro Surveill. 2010; 15 (2): 133-8.
  8. van’t Klooster T.M., Wielders C.C., Donker T. et al. Surveillance of Hospitalisations for 2009 pandemic influenza A (H1N1) in the Netherlands, 5 June - 31 December 2009. Euro Surveill. 2010; 15 (2): pii=19461.
  9. Hewagama S., Walker S.P., Stuart R.L., Gordon C., Johnson P.D., Friedman N.D. et al. 2009 H1N1 influenza A and pregnancy outcomes in Victoria, Australia. Clin. Infect. Dis. 2010; 50: 686-90.
  10. Siston A.M., Rasmussen S.A., Honein M.A. et al. Pandemic 2009 influenza A (H1N1) virus illness among pregnant women in the United States. J.A.M.A. 2010; 303: 1517-25.
  11. Черданцев А.П., Костинов М.П., Кусельман А.И., Лютая З.А., Кутбутдинова М.Х. Анализ анте и постнатального развития детей на фоне вакцинации беременных против гриппа. Российский вестник перинатологии и педиатрии. 2013; 2 (2): 30-4.
  12. Киселев О.И., Покровский В.И. Грипп при беременности: сочетание функциональной и инфекционной иммуносупрессии. СПб.: Принт; 2012.
  13. Harris J. W. Influenza occurring in pregnant women. J.A.M.A. 1919; 14: 978-80.
  14. Белокриницкая Т.Е., Трубицина А.Ю., Мурикова Е.А. Грипп A/H1N1, осложненный пневмониями, у беременных: течение беременности, исходы для матери и плода. В кн.: Материалы Всероссийской научно-практической конференции «Итоги эпидемии гриппа A/H1N1». Челябинск; 2011: 7-9.
  15. Зверев В.В., Костинов М.П., Черданцев А.П., Кусельман А.И., Киселев О.И., Ерофеева М.К. и др. Вакцинация беременных против гриппа. Федеральные клинические (методические) рекомендации. М.; 2015.
  16. Запольских А.М., Лыткина И.Н., Михеева И.В., Малышев Н.А., Базарова М.В., Серобян А.Г. Клинико-эпидемиологическая характеристика гриппа A (H1N1)pdm09 у беременных. Эпидемиология и вакцинопрофилактика. 2014; (1): 66-73.
  17. Ритова В.В. Роль вирусов в перинатальной и постнатальной патологии человека. М.: Медицина; 1976.
  18. Киселев О.И. Геном пандемического вируса А/H1N1v-2009. СПб.; М.: ИК «Димитрейд График Групп®»; 2011: 163.
  19. Костинов М.П., Кытько О.В., Афиногенова В.П. Вакцинация беременных против гриппа препаратом Агриппал S1. Эффективная фармакотерапия в акушерстве и гинекологии. 2010; 4: 50-3.
  20. Mor G., Cardenas I. The immune system in pregnancy: A unique complexity. Am. J. Reprod. Immunol. 2010; 63: 425-33.
  21. Jamieson D.J., Honein M.A., Rasmussen S.A. et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009; 374: 429-30.
  22. Lapinsky S.E. H1N1 novel influenza A in pregnant and immunocompromised patirnts. Crit. Care Med. 2010; 38: e52-7.
  23. Yawn D. H., Pyeatte J. C., Joseph J. M. et al. Transplacental transfer of influenza virus. J.A.M.A. 1971; 216: 1022-3.
  24. Kay A.W., Bayless N.L., Fukuyama J., Aziz N., Dekker C.L., Mackey S. et al. Pregnancy does not attenuate the antibody or plasmablast response to inactivated influenza vaccine. J. Infect. Dis. 2015; 212 (6): 861-70.
  25. Wkly Epidemiol. Rec. 2005; 80 (33): 277-88. http://www.who.int/entity/wer/2005/wer8033.pdf
  26. http://www.euro.who.int/en/home
  27. Черданцев А.П. Эффективность иммуноадъювантных вакцин против гриппа у беременных и оценка их безопасности для плода и новорожденных: Дисс. ... д-ра мед. наук. М.; 2013.
  28. Zaman K., Roy E., Arifeen S.E., Rahman M., Raqib R., Wilson E. et al. Effectiveness of maternal influenza immunization in mothers and infants. N. Engl. J. Med. 2008; 359 (15): 1555-64.
  29. England J.A., Walter E., Black S., Blatter M., Nyberg J., Ruben F.L., Decker M.D. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study. Pediatr. Infect. Dis. J. 2010; 29 (2): 105-10.
  30. Alexander W., Blish C.A. Immunogenicity and Clinical Efficacy of Influenza Vaccination in Pregnancy. Front. Immunol. 2015; 6: 289.
  31. Nitsch-Osuch A, Woźniak Kosek A, Brydak LB. Vaccination against influenza in pregnant women - safety and effectiveness. Ginekol. Pol. 2013; 84 (1): 56-61.
  32. Benowitz I., Esposito D.B., Gracey K.D., Shapiro E.D., Vazquez M. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin. Infect. Dis. 2010; 51 (12): 1355-61.
  33. Fell D.B., Sprague A.E., Ning Liu, Yasseen A.S. III, Shi-Wu Wen, Smith G., Walker M.C. H1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes. Am. J. Publ. Hlth. 2012; 102 (6): e33-40.
  34. McMillan M., Porritt K., Kralik D., Costi L., Marshall H. Influenza vaccination during pregnancy: A systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes. Vaccine. 2015; 33 (18): 2108-17.
  35. Poehling K.A., Szilagyi P.G., Staat M.A., Snively B.M., Payne D.C., Bridges C.B. et al. New vaccine surveillance network. Impact of maternal immunization on influenza hospitalizations in infants. Am. J. Obstet. Gynecol. 2011; 204 (6, Suppl. 1): 141-8.
  36. Silverman N. S., Greif A. Influenza vaccination during pregnancy. Patients’ and physicians’ attitudes. J. Reprod. Med. 2001; 46: 989-94.
  37. Lu P., Bridges C.B., Euler G.L., Singleton J.A. Influenza vaccination of recommended adult populations, U.S., 1989-2005. Vaccine. 2008; 26: 1786-93.
  38. Al-Safi Z.A., Shavell V.I., Gonik B. Vaccination in pregnancy. Women’s H-lth. 2011; 7 (1): 109-19.
  39. Receipt of influenza vaccine during pregnancy among women with live births-Georgia and Rhode Island, 2004-2007. Morbid Mortal Wkly Rep. 2009; 58: 972-5. http://www.ncbi.nlm.nih.gov/pubmed/19745804
  40. CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. Morbid Mortal Wkly Rep. 2008; 57 (No. RR-7).
  41. American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice. ACOG committee opinion number 305, November 2004. Influenza vaccination and treatment during pregnancy. Obstet. Gynecol. 2004; 104: 1125-6.
  42. Brewer N.T., Hallman W.K. Subjective and objective risk as predictors of influenza vaccination during the vaccine shortage of 2004-2005. Clin. Infect. Dis. 2006; 43: 1379-86.
  43. Костинов М.П., Ерофеева М.К., Харит С.М. Эффективность и безопасность вакцинопрофилактике гриппа у разных контингентов. Terra Medica. 2011; 2: 7-11.
  44. Pranita D.T., Kevin A., Carlos del Rio, Mark C. Steinhoff N.A. Halsey S.B.O. Safety of influenza vaccination during pregnancy. Am. J. Obstetr. Gynecol. 2009; 201 (6): 547-52.
  45. Ogburn T., Espey E.L., Contreras V., Arroyo P. Impact of clinic interventions on the rate of influenza vaccination in pregnant women. J. Reprod. Med. 2007; 52 (9): 753-6.
  46. Yuen C.Y., Tarrant M. Determinants of uptake of influenza vaccination among pregnant women - a systematic review. Vaccine. 2014; 32 (36): 4602-13.

Copyright (c) 2016 Eco-vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies